The Cultivated B breaks another barrier in cell-ag with new industrial-grade bioreactor

The Cultivated B (TCB) starts rapid-delivery manufacturing with its AUXO V industrial-grade bioreactor at its Burlington, Ont., plant. This addresses the cellular agriculture industry’s urgent need to increase global capacity in order to reach commercially viability.

It is a significant milestone because bioreactor delivery times could take up to two years. Producers of cultivated meats based on cellular agriculture and precision fermentation often face challenges in scaling up from lab to commercial manufacturing.

“Cellular agriculture is not a thing of the future. It has arrived,” said Dr. Hamid Noori, CEO of The Cultivated B. “The recent USDA approvals for cultivated meat producers are evidence that the industry is quickly advancing, but producers can’t scale their scientific and regulatory breakthroughs from the lab to commercial production without the ability to readily purchase and easily operate bioreactors. TCB is disrupting the industry in two ways: first, by aiming to make our industrial-grade bioreactors available with delivery times of only two to four weeks; and second, by designing a bioreactor that can be operated by non-experts with only a few days of training. We’re changing the game for the cellular agriculture industry.”